论文部分内容阅读
本文综合三个医院急性心肌梗塞（ＡＭＩ）溶栓治疗患者（治疗组）１１３例，对治疗结果予以回顾性分析。同时，与同期非溶栓治疗ＡＭＩ患者（对照组）１３０例对照分析。结果：①早期溶栓治疗与改善左心功能、提高冠脉再通率呈正相关，溶栓越早，剂量越大，疗效越高，若溶栓过迟，剂量再大，也不会有冠脉再通可能性，而且危险性愈高。②溶栓可降低ＡＭＩ近期与远期病死率，治疗组分别为０．８９％与１７．６８％，对照组分别为２．３１％与４０％（ｐ均＜０．０５）。③治疗组０．１７％患者溶栓后导致有症状性治疗后脑卒中，与对照组（４．６２％）无显著差异（ｐ＞０．０５）。指出正确掌握溶栓时机和剂量以及注意易出血高危ＡＭＩ，降低治疗后脑卒中发生的重要性。
In this paper, 113 patients with thrombolytic therapy of acute myocardial infarction (AMI) in three hospitals were retrospectively analyzed. At the same time, with the same period non-thrombolysis AMI patients (control group) control analysis of 130 cases. Results: (1) Early thrombolytic therapy can improve left heart function and improve the recanalization rate of coronary arteries. The earlier the thrombolysis, the higher the dose, the higher the curative effect. If the thrombolysis is too late and the dosage is too large, there will be no crown Pulse recanalization possibility, but the higher the risk. ② thrombolysis can reduce the recent and long-term mortality of AMI, the treatment group were 0.89% and 17.68%, respectively, the control group were 2.31% and 40% (p <0.05). ③ In the treatment group, 0.17% of the patients had stroke after symptomatic treatment after thrombolysis, which was not significantly different from that of the control group (4.62%) (p> 0.05). Pointed out the correct grasp of timing and dosage of thrombolytic therapy, and pay attention to the high risk of bleeding AMI, reducing the incidence of stroke after treatment.